Trial Profile
Quantitative evaluation of brain perfusion MRI with gadobutrol
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 19 Feb 2019
Price :
$35
*
At a glance
- Drugs Gadobutrol (Primary) ; Gadoterate-meglumine
- Indications Brain cancer
- Focus Diagnostic use
- 13 Feb 2019 Status changed from recruiting to completed.
- 05 Jul 2017 Status changed from not yet recruiting to recruiting.
- 16 Mar 2017 New trial record